Angiotensin Converting Enzyme Inhibition Early after Heart Transplantation

BACKGROUND: Cardiac allograft vasculopathy (CAV) remains a leading cause of mortality after heart transplantation (HT). Angiotensin converting enzyme inhibitors (ACEIs) may retard the development of CAV, but have not been well studied after HT. OBJECTIVES: We tested the safety and efficacy of the AC...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Am Coll Cardiol
Hlavní autoři: Fearon, William F., Okada, Kozo, Kobashigawa, Jon A., Kobayashi, Yuhei, Luikart, Helen, Sana, Sean, Daun, Tiffany, Chmura, Steven A., Sinha, Seema, Cohen, Garett, Honda, Yasuhiro, Pham, Michael, Lewis, David B., Bernstein, Daniel, Yeung, Alan C., Valantine, Hannah A., Khush, Kiran
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5546225/
https://ncbi.nlm.nih.gov/pubmed/28595700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2017.03.598
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky